Literature DB >> 2585468

Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy.

S Hodgson1, K Hart, S Abbs, J Heckmatt, E Rodillo, M Bobrow, V Dubowitz.   

Abstract

Cloned cDNA sequences representing exons from the Duchenne/Becker muscular dystrophy (DMD/BMD) gene were used for deletion screening in a population of 287 males males affected with DMD or BMD. The clinical phenotypes of affected boys were classified into three clinical severity groups based on the age at which ambulation was lost. Boys in group 1 had DMD, losing ambulation before their 13th birthday; those in group 2 had disease of intermediate severity, losing ambulation between the ages of 13 and 16 years; and boys in group 3 had BMD, being ambulant beyond 16 years. A fourth group consisted of patients too young to be classified. Clinical group allocation was made without previous knowledge of the DNA results. A gene deletion was found in 124 cases where the clinical severity group of the affected boy was known. The extent of the deletions was delineated using cDNA probes. There were 74 different deletions. Fifty-five of these were unique to individual patients, but the other 19 were found in at least two unrelated patients. The different clinical groups showed generally similar distributions of deletions, and the number of exon bands deleted (that is, deletion size) was independent of phenotype. Some specific deletion types, however, correlated with the clinical severity of the disease. Deletion of exons containing HindIII fragments 33 and 34 and 33 to 35 were associated with BMD and were not found in patients with DMD. Deletions 3 to 7 occurred in four patients with the intermediate phenotype and one patient with BMD. Other shared deletions were associated with DMD, although in four cases patients with disease of intermediate severity apparently shared the same deletion with boys with DMD. The range of phenotypes observed, and the overlap at the genetic level between severe and intermediate and mild and intermediate forms of dystrophy, emphasizes the essential continuity of the clinical spectrum of DMD/BMD. There were no characteristic deletions found in boys with mental retardation or short stature which differed from deletions in affected boys without these features.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2585468      PMCID: PMC1015738          DOI: 10.1136/jmg.26.11.682

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  34 in total

1.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

2.  Intelligence and the gene for Duchenne muscular dystrophy.

Authors:  E J Prosser; E G Murphy; M W Thompson
Journal:  Arch Dis Child       Date:  1969-04       Impact factor: 3.791

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Prolongation of walking in Duchenne muscular dystrophy with lightweight orthoses: review of 57 cases.

Authors:  J Z Heckmatt; V Dubowitz; S A Hyde; J Florence; A C Gabain; N Thompson
Journal:  Dev Med Child Neurol       Date:  1985-04       Impact factor: 5.449

5.  Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency.

Authors:  M Zatz; R T Betti; J A Levy
Journal:  Am J Med Genet       Date:  1981

6.  Clinical studies in benign (Becker type) X-linked muscular dystrophy.

Authors:  A E Emery; R Skinner
Journal:  Clin Genet       Date:  1976-10       Impact factor: 4.438

7.  Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences.

Authors:  H M Kingston; M Sarfarazi; N S Thomas; P S Harper
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion.

Authors:  L M Kunkel; A P Monaco; W Middlesworth; H D Ochs; S A Latt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.

Authors:  M H Brooke; G M Fenichel; R C Griggs; J R Mendell; R Moxley; J P Miller; M A Province
Journal:  Muscle Nerve       Date:  1983-02       Impact factor: 3.217

10.  Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome.

Authors:  K E Davies; P L Pearson; P S Harper; J M Murray; T O'Brien; M Sarfarazi; R Williamson
Journal:  Nucleic Acids Res       Date:  1983-04-25       Impact factor: 16.971

View more
  24 in total

Review 1.  The muscular dystrophies.

Authors:  V Dubowitz
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

2.  Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene.

Authors:  S Abbs; M Bobrow
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

3.  Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes.

Authors:  R G Roberts; T F Barby; E Manners; M Bobrow; D R Bentley
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

4.  A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods.

Authors:  S Abbs; S C Yau; S Clark; C G Mathew; M Bobrow
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

5.  Clinical, cytogenetic, and molecular analysis of three families with FRAXE.

Authors:  A J Barnicoat; Q Wang; J Turk; E Green; C G Mathew; G Flynn; V Buckle; M Hirst; K Davies; M Bobrow
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

6.  Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation.

Authors:  Emanuela Gussoni; Richard R Bennett; Kristina R Muskiewicz; Todd Meyerrose; Jan A Nolta; Irene Gilgoff; James Stein; Yiu-Mo Chan; Hart G Lidov; Carsten G Bönnemann; Arpad Von Moers; Glenn E Morris; Johan T Den Dunnen; Jeffrey S Chamberlain; Louis M Kunkel; Kenneth Weinberg
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis.

Authors:  S C Yau; M Bobrow; C G Mathew; S J Abbs
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

8.  Subclinical cardiomyopathy in Becker muscular dystrophy.

Authors:  S E Steare; V Dubowitz; A Benatar
Journal:  Br Heart J       Date:  1992-09

9.  Deletion mutations in Duchenne muscular dystrophy (DMD) in Western Saudi children.

Authors:  Mohammed T Tayeb
Journal:  Saudi J Biol Sci       Date:  2010-04-13       Impact factor: 4.219

10.  Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame.

Authors:  L V Nicholson; K M Bushby; M A Johnson; J T den Dunnen; I B Ginjaar; G J van Ommen
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.